Cloning, high level expression of human paraoxonase-3 in Sf9 cells and pharmacological characterization of its product

Biochem Pharmacol. 2005 Oct 1;70(7):1019-25. doi: 10.1016/j.bcp.2005.07.004.

Abstract

Human paraoxnase-3 (hPON3) (EC3.1.8.1) is a lipid-associated enzyme with antioxidant activity, and can inhibit the oxidation of low-density lipoprotein (LDL), thereby inhibiting early atherogenic process. In the present study, human PON3 gene was cloned from Human Fetal Liver Marathon-Ready cDNA and expressed in insect cells using baculovirus vector. Twenty-eight milligrams of purified recombinant hPON3 (rhPON3) was obtained from 1L Sf9 cells culture. The Km and Vmax values of rhPON3, with respective to phenylacetate hydrolysis were 7.46+/-4.40 mM and 89+/-10.54 U/mg (n=3). The kinetic parameters of Vmax and Km for dihydrocoumarin hydrolysis by rhPON3 were 698+/-248 U/mg and 0.84+/-0.24 mM (n=3). LDL oxidation assay indicated that rhPON3 could effectively protect LDL against copper-induced oxidation in vitro.

MeSH terms

  • Animals
  • Aryldialkylphosphatase
  • Baculoviridae / genetics
  • Base Sequence
  • Carboxylic Ester Hydrolases / metabolism
  • Cell Line
  • Cloning, Molecular
  • DNA Primers
  • Electrophoresis, Polyacrylamide Gel
  • Esterases / genetics*
  • Esterases / pharmacology*
  • Humans
  • Kinetics
  • Oxidation-Reduction
  • Recombinant Proteins / genetics
  • Recombinant Proteins / pharmacology
  • Spodoptera

Substances

  • DNA Primers
  • Recombinant Proteins
  • Esterases
  • Carboxylic Ester Hydrolases
  • arylesterase
  • Aryldialkylphosphatase
  • PON3 protein, human